WO2021127965A1 - Method for recycling voriconazole enantiomer - Google Patents
Method for recycling voriconazole enantiomer Download PDFInfo
- Publication number
- WO2021127965A1 WO2021127965A1 PCT/CN2019/127798 CN2019127798W WO2021127965A1 WO 2021127965 A1 WO2021127965 A1 WO 2021127965A1 CN 2019127798 W CN2019127798 W CN 2019127798W WO 2021127965 A1 WO2021127965 A1 WO 2021127965A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- voriconazole
- organic solvent
- enantiomers
- reaction
- recovering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- AYZDRTRWCASUFO-UHFFFAOYSA-N CCc(ncnc1)c1F Chemical compound CCc(ncnc1)c1F AYZDRTRWCASUFO-UHFFFAOYSA-N 0.000 description 1
- GFIHLMJUZQLCJQ-PXAZEXFGSA-N C[C@@H]([C@@](C1)(c(c(C)c2)ccc2F)[O]1[n]1ncnc1)c(ncnc1)c1F Chemical compound C[C@@H]([C@@](C1)(c(c(C)c2)ccc2F)[O]1[n]1ncnc1)c(ncnc1)c1F GFIHLMJUZQLCJQ-PXAZEXFGSA-N 0.000 description 1
- GCIVUQCLFQXCAH-BXUZGUMPSA-N Fc1cc(F)c([C@@H](C[n]2ncnc2)[C@H](c(ncnc2)c2F)[Cl]=[IH])cc1 Chemical compound Fc1cc(F)c([C@@H](C[n]2ncnc2)[C@H](c(ncnc2)c2F)[Cl]=[IH])cc1 GCIVUQCLFQXCAH-BXUZGUMPSA-N 0.000 description 1
- XCHRPVARHBCFMJ-UHFFFAOYSA-N O=C(C[n]1ncnc1)c(c(F)c1)ccc1F Chemical compound O=C(C[n]1ncnc1)c(c(F)c1)ccc1F XCHRPVARHBCFMJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Definitions
- the invention relates to the field of medicinal chemistry, in particular to a method for recovering voriconazole enantiomers.
- Voriconazole is a triazole antifungal and a second-generation synthetic derivative of fluconazole. It is the first-line treatment for invasive Aspergillus infection and Candida krusei infection. Its mechanism of action is to inhibit fungal cytochrome P450 (CYP450) end-dependent lanosterol 14 ⁇ demethylation to exert its antifungal effect, which is a crucial step in the synthesis of fungal cell membrane ergosterol. In vitro tests have shown that voriconazole has a broad-spectrum antifungal effect. It has antibacterial effects on all Candida species (including fluconazole-resistant Candida krusei, Candida glabrata and Candida albicans resistant strains).
- CYP450 fungal cytochrome P450
- Voriconazole has the advantages of broad antibacterial spectrum and strong antibacterial efficacy, especially for the advantages of good curative effect on invasive Aspergillus infection.
- Voriconazole (2R, 3S) is a chiral compound with two chiral centers in the structure, with two diastereomers (2R, 3R/2S, 3S) and one enantiomer (2S, 3R) .
- the physical and chemical properties of diastereoisomers are generally different, and they are easy to separate and remove during the production process.
- Enantiomers have the same physical and chemical properties as voriconazole in an achiral environment, and are difficult to separate and remove in the production process.
- the reported voriconazole is generally obtained by resolving the voriconazole racemate (2R, 3S/2S, 3R) with a chiral resolving agent.
- the recovery of the chiral resolving agent is relatively simple and can generally be used repeatedly.
- the yield of voriconazole (2R, 3S) obtained after resolution using a resolving agent is about 40%, and the voriconazole enantiomer (2S, 3R) obtained by resolution has two treatment methods, one is to Voriconazole isomers (2S, 3R) are converted to voriconazole, but because the voriconazole isomers (2S, 3R) contain two chiral centers for the conversion of isomers, four isomers 2S, 3R, 2R, 3S, 2R, 3R, and 2S, 3S, after the four isomers obtained are separated and resolved, the conversion efficiency of the obtained voriconazole is low, and the process flow is relatively complicated, which is not suitable for industrial production; the other is The enantiomers of voriconazole are treated directly as waste, which not only causes environmental pollution, but also increases production costs. Therefore, there is an urgent need for a method suitable for industrial processing of voriconazole isomers.
- the present invention discloses a method for recovering the enantiomers of voriconazole.
- the method has a simple process route, convenient operation in the treatment process, and the reaction process.
- the substances used are all commonly used substances in the experiment, which have the advantages of low harm to the human body, reuse of waste, environmental friendliness, and no waste of resources, and the substances obtained by the reaction can again become the starting materials for the preparation of voriconazole.
- the method for recovering the enantiomers of voriconazole of the present invention includes the following steps: mixing the enantiomers of voriconazole with a reaction solvent containing a basic substance A, heating to temperature I for reaction, and obtaining formula II and formula III after the reaction is completed ,
- the specific reaction is as follows:
- the reaction is completed, it is concentrated under reduced pressure, the concentrate is added with organic solvent A and water, the formula III is recovered and separated from the water layer, and the formula II is recovered from the oil layer.
- the concentrate is added with organic solvent A and water, stirred and dissolved, and then separated, the oil layer is collected, water is continued to be added to the oil layer, the pH value of the solution is adjusted with acidic substances, and the liquid is separated. Collect oil and water layers.
- the method for recovering the enantiomers of voriconazole of the present invention is to concentrate the collected oil layer, add a separating solvent and stir to dissolve, then cool to temperature II, stir and crystallize and filter with suction to obtain formula II; add organic solvent to the collected water layer B. Adjust the pH value of the solution with the alkaline substance B, separate the liquids, collect the organic solvent layer, and distill the organic solvent under reduced pressure, then heat to temperature III and distill under reduced pressure to obtain formula III.
- the mass ratio of the voriconazole enantiomers of formula I to the reaction solvent is 1:3 to 1:8, and the voriconazole enantiomers of formula I are basic
- the mass ratio of substance A is 3:1 ⁇ 7:1.
- the reaction solvent is one or two of methanol, ethanol, propanol, isopropanol, acetone and n-butanol
- the basic substance A is a strong base
- the strong alkaline substance is one or two of lithium hydroxide, sodium hydroxide and potassium hydroxide.
- the reaction temperature I of the voriconazole enantiomer of formula I and the basic substance A is 60-85° C., and the reaction time is 10-20 hours.
- the organic solvent A is one or two of toluene, dichloromethane and chloroform
- the acidic substance is hydrochloric acid, sulfuric acid, nitric acid and acetic acid.
- the pH of the solution is 1-5.
- the separation solvent is one or two of acetone, methyl acetate, ethyl acetate, ether and phenol; the temperature II is 0-10°C.
- the alkaline substance B is one or two of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, lithium hydroxide, sodium hydroxide and potassium hydroxide
- the organic solvent B is one or two of toluene, dichloromethane and chloroform, and the pH value of the solution is 8-12.
- the temperature III is 70°C to 90°C, and the pressure is -0.085 to -0.095 MPa.
- the 2,4-difluoro-2-[1-(1H-1,2,4-triazolyl)]acetophenone (formula II) is recovered The rate is 86%-95%, and the 6-ethyl-5-fluoropyrimidine (formula III) is 85%-95%.
- the method has the advantages of simple process route, convenient operation in the treatment process, the materials used in the reaction process are all commonly used in the experiment, little harm to the human body, repeated use of waste, environmental friendliness, no waste of resources, etc.
- the present invention The yields of the obtained products are all above 85%, and some can reach above 90%, and the separation of the products is simple, and the materials obtained by the reaction can be used as starting materials for preparing voriconazole.
- reagents used in the present invention can be purchased from the market or can be prepared by the method of the prior art or prepared by the method described in the present invention.
- °C degrees Celsius
- g grams
- Mpa megapascals
- h hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本发明涉及医药化学领域,具体涉及一种伏立康唑对映异构体的回收方法。The invention relates to the field of medicinal chemistry, in particular to a method for recovering voriconazole enantiomers.
伏立康唑(voriconazole)是一个三唑类抗真菌药和氟康唑的一个第二代合成衍生物,是侵袭性曲霉感染和克柔念珠菌感染的一线治疗药物。它的作用机制是通过抑制真菌中细胞色素P450(CYP450)端依赖的羊毛甾醇14α去甲基化发挥其抗真菌作用,这是真菌的细胞膜麦角固醇的合成至关重要的一步。体外试验表明伏立康唑具有广谱抗真菌作用,对所有的念珠菌属物种(包括耐氟康唑的克柔念珠菌、光滑念珠菌和白念珠菌耐药株)具有抗菌作用,对所有检测的曲霉菌属真菌具有杀菌作用,此外,伏立康唑在体外对其他致病性真菌也有杀菌作用,包括对现有抗真菌药敏感性较低的菌属,例如足放线病菌属和镰刀菌属。伏立康唑具有抗菌谱广,抗菌效力强的优点,尤其是对侵袭性曲霉菌浸泡感染疗效好的优点。Voriconazole is a triazole antifungal and a second-generation synthetic derivative of fluconazole. It is the first-line treatment for invasive Aspergillus infection and Candida krusei infection. Its mechanism of action is to inhibit fungal cytochrome P450 (CYP450) end-dependent lanosterol 14α demethylation to exert its antifungal effect, which is a crucial step in the synthesis of fungal cell membrane ergosterol. In vitro tests have shown that voriconazole has a broad-spectrum antifungal effect. It has antibacterial effects on all Candida species (including fluconazole-resistant Candida krusei, Candida glabrata and Candida albicans resistant strains). Fungi of the genus Moulds have bactericidal effects. In addition, voriconazole also has bactericidal effects against other pathogenic fungi in vitro, including those that are less sensitive to existing antifungal drugs, such as Actinomyces and Fusarium. Voriconazole has the advantages of broad antibacterial spectrum and strong antibacterial efficacy, especially for the advantages of good curative effect on invasive Aspergillus infection.
伏立康唑结构式如下:The structural formula of voriconazole is as follows:
伏立康唑(2R,3S)为手性化合物,结构中有两个手性中心,具有两个非对映异构体(2R,3R/2S,3S)和一个对映异构体(2S,3R)。其中非对映异构体物理化学性质一般不同,在生产工艺过程中易于分离,除去。对映异构体在非手性环境下与伏立康唑具有相同的物理、化学性质,生产工艺中难以分离除去。Voriconazole (2R, 3S) is a chiral compound with two chiral centers in the structure, with two diastereomers (2R, 3R/2S, 3S) and one enantiomer (2S, 3R) . Among them, the physical and chemical properties of diastereoisomers are generally different, and they are easy to separate and remove during the production process. Enantiomers have the same physical and chemical properties as voriconazole in an achiral environment, and are difficult to separate and remove in the production process.
已报道的伏立康唑一般是将伏立康唑消旋体(2R,3S/2S,3R)采用手性拆分剂进行拆分得到,手性拆分剂的回收比较简单,一般可以反复使用。使用拆分剂进行拆分后得到的伏立康唑(2R,3S)收率大概为40%左右,而拆分得到的伏立康唑对映异构体(2S,3R)有两种处理方法,一种是将伏立康唑异构体(2S,3R)向伏立康唑转化,但由于伏立康唑异构体(2S,3R)中含有两个手性中心翻转进行异构体的转化,能够得到四种异构体2S,3R、2R,3S、2R,3R、和2S,3S,将得到的四种异构体进行分离拆分后,得到的伏立康唑转化效率低,同时工艺流程比较复杂,不适合工业化生产;另一种是将伏立康唑对映异构体是直接当做废弃物处理,这样做不仅造成环境污染,还会增加生产成本。因此,急需一种适合工业化处理伏立康唑异 构体的方法。The reported voriconazole is generally obtained by resolving the voriconazole racemate (2R, 3S/2S, 3R) with a chiral resolving agent. The recovery of the chiral resolving agent is relatively simple and can generally be used repeatedly. The yield of voriconazole (2R, 3S) obtained after resolution using a resolving agent is about 40%, and the voriconazole enantiomer (2S, 3R) obtained by resolution has two treatment methods, one is to Voriconazole isomers (2S, 3R) are converted to voriconazole, but because the voriconazole isomers (2S, 3R) contain two chiral centers for the conversion of isomers, four isomers 2S, 3R, 2R, 3S, 2R, 3R, and 2S, 3S, after the four isomers obtained are separated and resolved, the conversion efficiency of the obtained voriconazole is low, and the process flow is relatively complicated, which is not suitable for industrial production; the other is The enantiomers of voriconazole are treated directly as waste, which not only causes environmental pollution, but also increases production costs. Therefore, there is an urgent need for a method suitable for industrial processing of voriconazole isomers.
发明内容Summary of the invention
为了解决以上两种处理伏立康唑对映异构体的方法存在的问题,本发明公开了一种伏立康唑对映异构体的回收方法,该方法具有工艺路线简单,处理过程中操作方便,反应过程中所用到的物质均是实验中常用物质,对人体危害小,对废弃物重复利用,对环境友好,不浪费资源等优点,而且反应得到的物质可以再次成为制备伏立康唑的起始物料。In order to solve the problems of the above two methods for processing the enantiomers of voriconazole, the present invention discloses a method for recovering the enantiomers of voriconazole. The method has a simple process route, convenient operation in the treatment process, and the reaction process. The substances used are all commonly used substances in the experiment, which have the advantages of low harm to the human body, reuse of waste, environmental friendliness, and no waste of resources, and the substances obtained by the reaction can again become the starting materials for the preparation of voriconazole.
本发明的伏立康唑对映异构体的回收方法,包括以下步骤,将伏立康唑对映异构体与含碱性物质A的反应溶剂混合,加热至温度I反应,反应结束后得到式II和式III,具体反应如下式:The method for recovering the enantiomers of voriconazole of the present invention includes the following steps: mixing the enantiomers of voriconazole with a reaction solvent containing a basic substance A, heating to temperature I for reaction, and obtaining formula II and formula III after the reaction is completed , The specific reaction is as follows:
本发明的伏立康唑对映异构体的回收方法,所述反应结束后,减压浓缩,浓缩物加入有机溶剂A和水,水层中回收分离式III,油层中回收式II。In the method for recovering voriconazole enantiomers of the present invention, after the reaction is completed, it is concentrated under reduced pressure, the concentrate is added with organic solvent A and water, the formula III is recovered and separated from the water layer, and the formula II is recovered from the oil layer.
本发明的伏立康唑对映异构体的回收方法,所述浓缩物加入有机溶剂A和水搅拌溶解后分液,收集油层,在油层中继续加水,用酸性物质调节溶液的pH值,分液,收集油层和水层。In the method for recovering voriconazole enantiomers of the present invention, the concentrate is added with organic solvent A and water, stirred and dissolved, and then separated, the oil layer is collected, water is continued to be added to the oil layer, the pH value of the solution is adjusted with acidic substances, and the liquid is separated. Collect oil and water layers.
本发明的伏立康唑对映异构体的回收方法,将收集的油层浓缩,加入分离溶剂搅拌溶解后,降温至温度II,搅拌析晶后抽滤,得到式II;在收集的水层加入有机溶剂B,用碱性物质B调节溶液的pH值,分液,收集有机溶剂层,减压蒸馏去除有机溶剂后,加热至温度III减压蒸馏得到式III。The method for recovering the enantiomers of voriconazole of the present invention is to concentrate the collected oil layer, add a separating solvent and stir to dissolve, then cool to temperature II, stir and crystallize and filter with suction to obtain formula II; add organic solvent to the collected water layer B. Adjust the pH value of the solution with the alkaline substance B, separate the liquids, collect the organic solvent layer, and distill the organic solvent under reduced pressure, then heat to temperature III and distill under reduced pressure to obtain formula III.
本发明的伏立康唑对映异构体的回收方法,所述式I伏立康唑对映异构体与反应溶剂质量比为1:3~1:8,所述式I伏立康唑对映异构体与碱性物质A质量比为3:1~7:1。In the method for recovering voriconazole enantiomers of the present invention, the mass ratio of the voriconazole enantiomers of formula I to the reaction solvent is 1:3 to 1:8, and the voriconazole enantiomers of formula I are basic The mass ratio of substance A is 3:1~7:1.
本发明的伏立康唑对映异构体的回收方法,所述反应溶剂为甲醇、乙醇、丙醇、异丙醇、丙酮和正丁醇中的一种或两种,所述碱性物质A为强碱性物质,所述强碱性物质为氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种。In the method for recovering voriconazole enantiomers of the present invention, the reaction solvent is one or two of methanol, ethanol, propanol, isopropanol, acetone and n-butanol, and the basic substance A is a strong base The strong alkaline substance is one or two of lithium hydroxide, sodium hydroxide and potassium hydroxide.
本发明的伏立康唑对映异构体的回收方法,所述式I伏立康唑对映异构体与碱性物质A的反应的温度I为60~85℃,反应时间为10~20小时。In the method for recovering voriconazole enantiomers of the present invention, the reaction temperature I of the voriconazole enantiomer of formula I and the basic substance A is 60-85° C., and the reaction time is 10-20 hours.
本发明的伏立康唑对映异构体的回收方法,所述有机溶剂A为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述酸性物质为盐酸、硫酸、硝酸和乙酸中的一种或两种,所述溶液pH值为1~5。In the method for recovering the enantiomers of voriconazole of the present invention, the organic solvent A is one or two of toluene, dichloromethane and chloroform, and the acidic substance is hydrochloric acid, sulfuric acid, nitric acid and acetic acid. One or two, the pH of the solution is 1-5.
本发明的伏立康唑对映异构体的回收方法,所述分离溶剂为丙酮、乙酸甲酯、乙酸乙酯、乙醚和苯酚中的一种或两种;所述温度II为0~10℃。In the method for recovering voriconazole enantiomers of the present invention, the separation solvent is one or two of acetone, methyl acetate, ethyl acetate, ether and phenol; the temperature II is 0-10°C.
本发明的伏立康唑对映异构体的回收方法,所述碱性物质B为碳酸钠、碳酸钾、醋酸钠、醋酸钾、氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种,所述有机溶剂B为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述溶液pH值为8~12。In the method for recovering voriconazole enantiomers of the present invention, the alkaline substance B is one or two of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, lithium hydroxide, sodium hydroxide and potassium hydroxide The organic solvent B is one or two of toluene, dichloromethane and chloroform, and the pH value of the solution is 8-12.
本发明的伏立康唑对映异构体的回收方法,所述温度III为70℃~90℃,所述压力为-0.085~-0.095MPa。In the method for recovering voriconazole enantiomers of the present invention, the temperature III is 70°C to 90°C, and the pressure is -0.085 to -0.095 MPa.
本发明的伏立康唑对映异构体的回收方法,所述2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮(式II)的收率为86%~95%,所述6-乙基-5-氟嘧啶(式III)为85%~92%。In the method for recovering the enantiomers of voriconazole of the present invention, the 2,4-difluoro-2-[1-(1H-1,2,4-triazolyl)]acetophenone (formula II) is recovered The rate is 86%-95%, and the 6-ethyl-5-fluoropyrimidine (formula III) is 85%-95%.
该方法具有工艺路线简单,处理过程中操作方便,反应过程中所用到的物质均是实验中常用物质,对人体危害小,对废弃物重复利用,对环境友好,不浪费资源等优点,本发明所得的产物的收率均在85%以上,部分能达到90%以上,且产物分离简单,反应制得物质可作为制备伏立康唑的起始物料。The method has the advantages of simple process route, convenient operation in the treatment process, the materials used in the reaction process are all commonly used in the experiment, little harm to the human body, repeated use of waste, environmental friendliness, no waste of resources, etc. The present invention The yields of the obtained products are all above 85%, and some can reach above 90%, and the separation of the products is simple, and the materials obtained by the reaction can be used as starting materials for preparing voriconazole.
为了使本领域的技术人员更好地理解本发明的技术方案,下面进一步披露一些非限制实施例对本发明作进一步的详细说明。本发明所使用的试剂均可以从市场上购得或者可以通过现有技术的方法制备或者通过本发明所描述的方法制备而得。In order to enable those skilled in the art to better understand the technical solutions of the present invention, some non-limiting embodiments are further disclosed below to further describe the present invention in detail. The reagents used in the present invention can be purchased from the market or can be prepared by the method of the prior art or prepared by the method described in the present invention.
本发明中,℃表示摄氏度,g表示克,Mpa表示兆帕,h表示小时。In the present invention, °C represents degrees Celsius, g represents grams, Mpa represents megapascals, and h represents hours.
实施例1Example 1
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化锂20g,升温65℃反应10h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A三氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A三氯甲烷层,在收集的三氯甲烷层中继续加入200g水,用浓硫酸调节pH至1,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of lithium hydroxide into the reaction flask, and react at 65° C. for 10 hours. After the reaction is completed, the methanol is recovered by concentration under reduced pressure. The concentrate is added with 400g of organic solvent A chloroform and 200g of water after stirring to dissolve, then stand for liquid separation, collect the organic solvent A chloroform layer, and continue to add to the collected chloroform layer 200g water, adjust the pH to 1 with concentrated sulfuric acid, separate the liquids, and collect the oil layer and the water layer.
将最后收集的有机溶剂A三氯甲烷层浓缩至干,加入分离溶剂乙酸甲酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为86.29%。Concentrate the collected organic solvent A chloroform layer to dryness, add 200g of separation solvent methyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4h, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 86.29%.
水层加入200g有机溶剂B三氯甲烷,用醋酸钠溶液调节pH为8,分液,收集有机溶 剂B三氯甲烷层,30℃减压蒸馏去除有机溶剂B三氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为85.33%。Add 200g of organic solvent B chloroform to the water layer, adjust the pH to 8 with sodium acetate solution, separate the layers, collect the organic solvent B chloroform layer, and distill the organic solvent B chloroform under reduced pressure at 30°C, then reduce pressure at 70°C To -0.095Mpa, 6-ethyl-5-fluoropyrimidine (compound of formula III) was obtained by distillation, and the yield was 85.33%.
实施例2Example 2
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂丙酮400g和氢氧化钾20g,升温75℃回流反应20h。反应结束之后减压浓缩回收丙酮,浓缩物加入有机溶剂A甲苯400g和200g水搅拌溶解后,静置分液,收集有机溶剂A甲苯层,在甲苯层中继续加入200g水,用浓硝酸调节pH至5,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of acetone as the reaction solvent, and 20 g of potassium hydroxide into the reaction flask, and react with reflux at 75°C for 20 hours. After the reaction is completed, the acetone is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A toluene and 200g of water and stirred to dissolve, then stand for liquid separation, collect the organic solvent A toluene layer, continue to add 200g of water to the toluene layer, adjust the pH with concentrated nitric acid To 5, separate liquid, collect oil layer and water layer.
将最后收集的有机溶剂A甲苯层浓缩至干,加入分离溶剂乙醚200g搅拌溶解后,降温至8℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为88.27%。The toluene layer of the organic solvent A collected at the end was concentrated to dryness. After adding 200g of the separating solvent ether and stirring to dissolve, the temperature was lowered to 8°C, stirred and crystallized for 4h, and filtered with suction to obtain 2,4-difluoro-2-[1-(1H -1,2,4-triazolyl)] crude acetophenone (compound of formula II), the yield was 88.27%.
水层加入200g有机溶剂B甲苯,用25%的氢氧化钾溶液调节pH为12,分液,收集有机溶剂B甲苯层,30℃减压蒸馏去除有机溶剂B甲苯后,90℃减压至-0.085Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为87.52%。Add 200 g of organic solvent B toluene to the water layer, adjust the pH to 12 with 25% potassium hydroxide solution, separate the layers, collect the organic solvent B toluene layer, distill the organic solvent B toluene off under reduced pressure at 30°C, and then reduce pressure at 90°C to- 0.085Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 87.52%.
实施例3Example 3
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温85℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓盐酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 85°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated hydrochloric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为93.84%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 93.84%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为10,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为91.37%。Add 200g of organic solvent B dichloromethane to the water layer, adjust the pH to 10 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 91.37%.
实施例4Example 4
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和碳酸钠20g,升温65℃回流反应10h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至1,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of sodium carbonate into the reaction flask, and reflux at 65° C. for reaction for 10 hours. After the reaction, the methanol was recovered by concentration under reduced pressure. The concentrate was added with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stood still for liquid separation, collected the dichloromethane layer of organic solvent A, and continued to add 200g of water to the dichloromethane layer , Adjust the pH to 1 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解 后,降温至0℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为50.96%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separation solvent ethyl acetate and stir to dissolve, then cool to 0°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II) has a yield of 50.96%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为9,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为43.58%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 9 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 70°C 0.095Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 43.58%.
实施例5Example 5
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和醋酸钠20g,升温80℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomers, 400 g of ethanol as the reaction solvent and 20 g of sodium acetate into the reaction flask, and react with reflux at 80° C. for 15 hours. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为41.78%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 41.78%.
水层加入200g有机溶剂B二氯甲烷,用醋酸钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为37.62%。Add 200g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with sodium acetate solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, reduce pressure at 80°C to -0.09Mpa, and distill 6-ethyl-5-fluoropyrimidine (compound of formula III) was obtained with a yield of 37.62%.
实施例6Example 6
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化钠20g,升温30℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 30°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为39.84%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 39.84%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为9,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为33.71%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 9 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 70°C 0.095Mpa, distillation to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 33.71%.
实施例7Example 7
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化钠20g,升温50℃回流反应15h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g 和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomers, 400 g of reaction solvent methanol and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 50°C. After the reaction is completed, the methanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the organic solvent A dichloromethane layer, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为58.64%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 58.64%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为51.47%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with 25% sodium hydroxide solution, separate the liquids, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (the compound of formula III), the yield was 51.47%.
实施例8Example 8
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温20℃回流反应15h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of the voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and react with reflux at 20° C. for 15 hours. After the reaction, the methanol was recovered by concentration under reduced pressure. The concentrate was added with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stood still for liquid separation, collected the dichloromethane layer of organic solvent A, and continued to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为38.71%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 38.71%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为33.71%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with 25% sodium hydroxide solution, separate the liquids, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 33.71%.
实施例9Example 9
在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温40℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硝酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at a temperature of 40°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated nitric acid, separate the liquids, and collect the oil and water layers.
将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为49.21%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (the compound of formula II), the yield was 49.21%.
水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为10,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为43.85%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 10 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce the pressure to-at 70°C 0.095Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (the compound of formula III), the yield was 43.85%.
Claims (10)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2019/127798 WO2021127965A1 (en) | 2019-12-24 | 2019-12-24 | Method for recycling voriconazole enantiomer |
| CN201980103211.9A CN114829354A (en) | 2019-12-24 | 2019-12-24 | Recovery method of voriconazole enantiomer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2019/127798 WO2021127965A1 (en) | 2019-12-24 | 2019-12-24 | Method for recycling voriconazole enantiomer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2021127965A1 true WO2021127965A1 (en) | 2021-07-01 |
Family
ID=76573416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2019/127798 Ceased WO2021127965A1 (en) | 2019-12-24 | 2019-12-24 | Method for recycling voriconazole enantiomer |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN114829354A (en) |
| WO (1) | WO2021127965A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113788819A (en) * | 2021-08-26 | 2021-12-14 | 湖南复瑞生物医药技术有限责任公司 | Preparation method of voriconazole |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011096697A2 (en) * | 2010-02-04 | 2011-08-11 | Dongkook Pharmaceutical Co., Ltd. | Process for preparing voriconazole by using new intermediates |
| CN106117186A (en) * | 2016-06-12 | 2016-11-16 | 重庆莱美隆宇药业有限公司 | A kind of preparation method of voriconazole and its intermediate |
| CN107827876A (en) * | 2017-10-27 | 2018-03-23 | 江苏理工学院 | A kind of preparation method of voriconazole raceme |
| CN109705102A (en) * | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | The preparation method of voriconazole and its intermediate |
-
2019
- 2019-12-24 WO PCT/CN2019/127798 patent/WO2021127965A1/en not_active Ceased
- 2019-12-24 CN CN201980103211.9A patent/CN114829354A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011096697A2 (en) * | 2010-02-04 | 2011-08-11 | Dongkook Pharmaceutical Co., Ltd. | Process for preparing voriconazole by using new intermediates |
| CN106117186A (en) * | 2016-06-12 | 2016-11-16 | 重庆莱美隆宇药业有限公司 | A kind of preparation method of voriconazole and its intermediate |
| CN107827876A (en) * | 2017-10-27 | 2018-03-23 | 江苏理工学院 | A kind of preparation method of voriconazole raceme |
| CN109705102A (en) * | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | The preparation method of voriconazole and its intermediate |
Non-Patent Citations (2)
| Title |
|---|
| DUAN XIYU, LIU XIAO-ZHOU;LI LIN;LIU JIA-XIN;YU ZHI-GUO;ZHAO YUN-LI: "Determination of Related Substances in Voriconazole Freeze-Dried Ophthalmic Preparation by HPLC", SHENYANG YAOKE DAXUE XUEBAO - JOURNAL OF SHENYANG PHARMACEUTICAL UNIVERSITY., CHINESE ELECTRONIC PERIODICAL SERVICES, LIAONING, CN, vol. 33, no. 12, 1 December 2016 (2016-12-01), LIAONING, CN, pages 958 - 964, XP055827321, ISSN: 1006-2858, DOI: 10.14066 /j.cnki.cn21-1349 /r.2016.12.008 * |
| SERVAIS ANNE-CATHERINE; MOLDOVAN RADU; FARCAS ELENA; CROMMEN JACQUES; ROLAND ISABELLE; FILLET MARIANNE: "Development and validation of a liquid chromatographic method for the stability study of a pharmaceutical formulation containing voriconazole using cellulose tris(4-chloro-3-methylphenylcarbamate) as chiral selector and polar organic mobile phases", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 1363, 1 July 2014 (2014-07-01), AMSTERDAM, NL, pages 178 - 182, XP029063808, ISSN: 0021-9673, DOI: 10.1016/j.chroma.2014.06.082 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113788819A (en) * | 2021-08-26 | 2021-12-14 | 湖南复瑞生物医药技术有限责任公司 | Preparation method of voriconazole |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114829354A (en) | 2022-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502909A5 (en) | ||
| EP3395813B1 (en) | Voriconazole intermediate and voriconazole synthesis method | |
| CN105348172B (en) | (S) preparation method of the preparation of the mesyl ethamine of 1 (ethyoxyl of 4 methoxyl group 3) phenyl 2 and Apremilast | |
| US12258330B2 (en) | Method for preparing voriconazole and intermediate thereof | |
| US9469593B2 (en) | Process for preparing cinacalcet hydrochloride | |
| CN113880744B (en) | A chiral separation method for Brivaracetam | |
| CN101260092B (en) | Method for preparing cinepazide maleate | |
| CN107445921B (en) | A kind of preparation method, product and application of product of high-purity eugenol epoxy | |
| WO2021127965A1 (en) | Method for recycling voriconazole enantiomer | |
| CN103044468B (en) | Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid | |
| CN100379736C (en) | The preparation method of entecavir | |
| CN116332774A (en) | A kind of preparation method of metaraminol tartrate with high chiral purity | |
| EP3201171A1 (en) | Method of preparing intermediate of salmeterol | |
| CN104961787B (en) | Synthetic method of cordycepin | |
| JP2005517000A (en) | Process for producing β-cryptoxanthin and α-cryptoxanthin from commercially available lutein | |
| EP3511326A1 (en) | Method for preparing voriconazole l-camphorsulphonate and voriconazole | |
| CN110776475A (en) | A kind of synthetic method of oxadiazon | |
| CN119930447A (en) | A preparation method of meta-hydroxylamine bitartrate | |
| WO2007080470A2 (en) | A method for the purification of levetiracetam | |
| CN110683992B (en) | Method for synthesizing econazole nitrate by one-pot method | |
| CN104876812B (en) | Process for preparing sertraline hydrochloride intermediates and impurities | |
| US20120253051A1 (en) | Process for the preparation of ropinirole and salts thereof | |
| CN109293587B (en) | Preparation method of clofazimine and intermediate thereof | |
| CN112300150B (en) | Preparation method of milpitant and intermediate thereof | |
| CN113956239A (en) | Azelastine hydrochloride, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19957875 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19957875 Country of ref document: EP Kind code of ref document: A1 |